Mouse models of kras-mutant colorectal cancer: Valuable gemms for drug testing?

Research output: Contribution to journalArticle

Abstract

The development of effective therapies for colorectal cancer depends on the ability of preclinical models to faithfully recapitulate the molecular and biologic behavior of human tumors. This study reports on the characterization of colorectal genetically engineered mouse models and their derivative cell lines carrying wild-type or oncogenic Kras with concomitant Apc and p53 loss.

Original languageEnglish
Pages (from-to)2794-2796
Number of pages3
JournalClinical Cancer Research
Volume19
Issue number11
DOIs
Publication statusPublished - Jun 1 2013

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Mouse models of kras-mutant colorectal cancer: Valuable gemms for drug testing?'. Together they form a unique fingerprint.

  • Cite this